Top Growth Stocks Trading at a Discount
Top 5 Mid-Cap Stocks at Discount
Last Updated: 31st July 2023 - 09:53 am
Mid-cap companies as the name indicate, fall right in the middle, between large and small-cap companies. Mid-cap stocks are the respective shares of the companies that comprise a market capitalization in between ₹ 5,000 Crore to ₹20,000 Crore. As per SEBI, the listed companies which are ranked from 101 to 250 company in the Indian stock exchanges (NSE & BSE) in the terms of market capitalization are said to be Mid-Cap Stocks. Bharat Electronics, Exide Industries, Bharat Forge, etc. are some of the Mid-cap stocks. Nifty has a benchmark Mid-cap Index in India known as Nifty Midcap 50 which holds the top 50 most traded mid-cap stocks in the market.
The mid-cap stocks at discount are:
1. Piramal Enterprises
The Piramal Enterprise share price has decreased by 53% from its 52-week high of Rs 2084, with the previous close on 20 July' 2023 at Rs 976. The average estimated share price target is Rs 1095, a potential upside of around 12%.
Key Highlights:
I. Strategic Loan Mix: PEL aims to shift loan mix towards retail lending (67% of AUM by FY26) to mitigate cyclicality in the wholesale business.
II. De-risking Wholesale Book: PEL enhanced granularity and provisioned 55% for Stage-3 assets in the wholesale book, with positive developments expected from FY23-24 onwards.
III. Potential Stake Unlocking: PEL holds an 8.34% stake in Shriram Finance, which may be unlocked in the next 12-18 months, providing additional value to shareholders
IV. Expansion in Retail Business: PEL is expanding unsecured lending by partnering with Fintech and Consumer Tech companies, offering an attractive yield of 18% on advances and a robust ROA of around 5%.
Key Risks:
Potential risks include slower retail lending growth, delayed resolution in Wholesale 1.0, and unforeseen issues in Wholesale 2.0 despite risk management measures.
Financial Performance:
Robust Balance Sheet: PEL maintains a strong balance sheet with a net worth of ₹ 31,000cr and cash & liquid investments of ₹ 7,430cr as of March 2023.
Outlook:
he company is showing great growth trajectory to cross the current valuation of the stock.
Financial Summary:
Y/E Mar (Cr) |
FY23 |
NII |
4,893 |
NIM (%) |
5.85 |
PPOP |
2,830 |
PAT |
1,514 |
BV (Rs.) |
1,301 |
PBV |
0.59 |
ROE |
5.61 |
ROA |
1.65 |
2. Gland Pharma
The Gland Pharma share price has decreased by 53% from its 52-week high of ₹ 2606, with the previous close on 20 July' 2023 at ₹ 1237. The average estimated share price target is ₹ 1429, a potential upside of around 16%.
Key Highlights:
I. US Market: GLAND's revenue decline in the US market was attributed to inventory rationalization, high price pressure, and a higher base from COVID-19 related products sales.
II. India Business: Impact on business due to production line shutdown and reduced business from domestic B2C division.
III. RoW Business: Softer off-take in the ROW market and penem production line shutdown as part of capacity expansion.
Key Risks:
I. USFDA inspection outcomes may impact revenue growth.
II. Entry of new players could increase pricing pressure in the injectable portfolio.
III. Delay in launching Biosimilar in the market.
Financial Performance:
I. Revenue declined by 28.8% YoY, with weak performance in the US, India, and RoW markets.
II. Gross margins improved by 300bps, EBITDA margins at 21.5% down 100bps.
III. Reported PAT fell by 72% YoY due to lower sales and low operating profitability.
Outlook:
Expecting similar growth for GLAND in core markets and high single-digit growth in India and RoW over the long term
Financial Summary:
Y/E Mar (Cr) |
FY23 |
Net Sales |
3,617 |
EBITDA |
1,019 |
Net Profit |
776 |
EPS (Rs) |
47 |
P/BV (x) |
16.6 |
EV/EBITDA (x) |
2.7 |
ROE (%) |
11 |
3. Rajesh Exports
The Rajesh Exports share price has decreased by 50% from its 52-week high of ₹ 1028, with the previous close on 20 July' 2023 at ₹ 517. The average estimated share price target is ₹ 1100, a potential upside of around 113%.
Key Highlights:
Rajesh Exports Signed Pact for Lithium-ion Cell Factory:
I. Bengaluru-based Rajesh Exports signs pact with Ministry of Heavy Industries and Karnataka government.
II. The agreement is for setting up a 5 GWh lithium-ion cell factory in Karnataka.
III. The project is part of the ₹ 181 billion production-linked incentive (PLI) program for advanced chemistry lithium-ion cells.
Government Support and Incentives:
I. Ministry of Heavy Industries and Karnataka government assure all required support for the Giga Factory.
II. Tailor-made incentive package provided by the state government for the project.
Key Risk:
Dividend pay-out has been low at 2.83% of profits over last 3 year.
Financial Performance:
I. Company is almost debt free.
II. Company is expected to give good quarter.
Outlook:
The company is the single largest constituent of the gold business. Rajesh Exports aims to foray into advanced technology solutions for clean and green energy storage.
Financial Summary:
Y/E Mar (Cr) |
FY23 |
Net Sales |
3,39,690 |
EBITDA |
1,555 |
Net Profit |
1,478 |
EPS (Rs) |
49 |
P/BV (x) |
1.03 |
EV/EBITDA (x) |
8.8 |
ROE (%) |
10.05 |
4. Aarti Industries
The Aarti Industries share price has decreased by 50% from its 52-week high of ₹ 924, with the previous close on 20 July' 2023 at ₹ 466. The average estimated share price target is ₹ 562, a potential upside of around 21%.
Key Highlights:
I. Established in 1984, Aarti Industries is a global specialty chemical company.
II. Operates in key value chains with a major presence in the US, Europe, and Japan.
III. Holds a top-five global ranking for 75% of its portfolio.
IV. 200+ products sold to 700+ domestic and 400+ export customers in 60 countries.
Key Risk and Financial Performance:
I. Challenging FY23 due to global supply chain disruptions and inflationary pressures.
II. Chemical business EBITDA grew over 2x in the last five yea₹
III. Commercialized new facilities and ongoing expansions on track.
IV. Volume growth expected to be robust in FY24 (~25%).
V. EBITDA growth guidance remains unchanged at 25%.
VI. Capex projects to be commissioned in FY24-25 for further capacity expansion.
Outlook:
I. Upcoming capex of₹ 2500-3000 crore to boost specialty chemical revenue growth.
II. Increasing share of value-added business portfolio.
III. Expanding product range with new chemistries and value-added products.
Financial Summary:
Y/E Mar (Cr) |
FY23 |
Net Revenue |
6,619 |
EBITDA |
1,089 |
EBITDA Margin |
17% |
PAT |
546 |
EPS (Rs) |
15 |
EV/EBITDA (x) |
30 |
PE (x) |
54 |
ROE (%) |
11 |
ROCE (%) |
10 |
5. Adani Power
The Adani Power share price has decreased by 44% from its 52-week high of ₹ 433, with the previous close on 20 July' 2023 at ₹ 244.
Key Highlights:
I. The project in Mannar and Pooneryn in Sri Lanka's Northern Province will be completed by January 2025.
II. The projects include a 500 MW wind project, development of Colombo Port West Container Terminal, and producing green Hydrogen.
III. The total investment in the projects is nearly $1 billion, showcasing Adani Group's growing footprint in the regional port and energy sector. The Group previously entered the Colombo Port project as the majority stakeholder after a different development plan was cancelled.
Renewable Energy Cooperation and Development in Sri Lanka:
Sri Lanka and India signed agreements on renewable energy cooperation and development of Trincomalee as an energy hub. A permit for a joint venture between Ceylon Electricity Board & NTPC for a solar park in Sampur, Trincomalee district, was issued.
Key Risk:
I. Company is not paying out dividend
II. Promoters have pledged 25.1% of their holding.
Financial Performance:
I. Company has delivered good profit growth of 48.1% CAGR over last 5 year
II. Company's working capital requirements have reduced from 103 days to 74.2 days.
Outlook:
I. This company is likely to have a strong quarter.
II. Over the past 5 year, it has shown impressive profit growth at an average rate of 48.1% annually and expected to maintain.
Financial Summary:
Y/E Mar (Cr) |
FY23 |
Net Revenue |
38,773 |
EBITDA |
10,096 |
EBITDA Margin |
26% |
PAT |
7,675 |
EPS (Rs) |
28 |
EV/EBITDA (x) |
9.3 |
PE (x) |
8.5 |
ROE (%) |
44 |
ROCE (%) |
15.8 |
Top 5 Mid-Cap Stocks at Discount:
Stock Name |
CMP |
Target |
Potential Upside |
Rs. 1091.55 |
Rs. 1095 |
12% |
|
Rs. 1197.8 |
Rs. 1429 |
16% |
|
Rs. 513.45 |
Rs. 1100 |
113% |
|
Rs. 464.5 |
Rs. 562 |
21% |
|
Rs. 256.00 |
Rs. 300 |
22% |
*Summary(as on 26th July 2023)
Trending on 5paisa
04
5paisa Research Team
Discover more of what matters to you.
Indian Stock Market Related Articles
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.